The Effects of Adding TCM-700C on the Standard Combination Treatment for Patients With Genotype 1 Hepatitis C Infection

NCT00556504 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

84

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Hepatitis C

Interventions

DRUG: TCM-700C
DRUG: Peginterferon alfa-2a
DRUG: Ribavirin
DRUG: Placebo

Sponsor

TCM Biotech International Corp.